Xi Li Selected Research

Colonic Neoplasms (Colon Cancer)

1/2023	Cholesterol removal improves performance of a model biomimetic system to co-deliver a photothermal agent and a STING agonist for cancer immunotherapy.
1/2023	Minimal residual disease (MRD) detection in solid tumors using circulating tumor DNA: a systematic review.
1/2021	MicroRNA-19b Downregulates NR3C1 and Enhances Oxaliplatin Chemoresistance in Colon Cancer via the PI3K/AKT/mTOR Pathway.
1/2018	Structure-Dependent Modulation of Aryl Hydrocarbon Receptor-Mediated Activities by Flavonoids.
6/2016	Association of well-characterized lung cancer lncRNA polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response.
12/2015	Sulindac sulfide inhibits colon cancer cell growth and downregulates specificity protein transcription factors.
10/2014	Diindolylmethane analogs bind NR4A1 and are NR4A1 antagonists in colon cancer cells.
2/2014	Tolfenamic acid inhibits colon cancer cell and tumor growth and induces degradation of specificity protein (Sp) transcription factors.
8/2007	Possible mechanism for the regulation of glucose on proliferation, inhibition and apoptosis of colon cancer cells induced by sodium butyrate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xi Li Research Topics

Disease

177	Neoplasms (Cancer) 05/2024 - 09/2002
51	Inflammation (Inflammations) 05/2024 - 03/2007
47	Infections 01/2024 - 08/2007
45	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 06/2004
29	Breast Neoplasms (Breast Cancer) 04/2024 - 06/2006
25	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 02/2010
25	Lung Neoplasms (Lung Cancer) 04/2024 - 05/2005
23	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 05/2011
22	Myocardial Infarction 12/2021 - 06/2013
20	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 06/2010
20	Neoplasm Metastasis (Metastasis) 01/2023 - 06/2006
16	Obesity 04/2024 - 09/2006
16	Fibrosis (Cirrhosis) 03/2024 - 11/2016
16	Wounds and Injuries (Trauma) 11/2023 - 12/2014
15	Insulin Resistance 05/2024 - 06/2006
13	Type 2 Diabetes Mellitus (MODY) 05/2024 - 08/2014
13	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 01/2013
12	Hypertension (High Blood Pressure) 01/2024 - 04/2005
12	Adenocarcinoma of Lung 07/2022 - 01/2014
12	Ischemic Stroke 01/2022 - 08/2010
11	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 09/2006
11	Carcinoma (Carcinomatosis) 07/2020 - 04/2002
10	Liver Diseases (Liver Disease) 05/2024 - 11/2011
10	Non-alcoholic Fatty Liver Disease 03/2024 - 12/2015
10	COVID-19 01/2024 - 01/2020
10	Hypoxia (Hypoxemia) 11/2023 - 09/2011
10	Parkinson Disease (Parkinson's Disease) 08/2023 - 01/2018
10	Melanoma (Melanoma, Malignant) 01/2023 - 06/2013
10	Body Weight (Weight, Body) 01/2022 - 05/2014
10	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 05/2006
9	Coronary Disease (Coronary Heart Disease) 04/2024 - 05/2011
9	Sepsis (Septicemia) 01/2023 - 06/2012
9	Colonic Neoplasms (Colon Cancer) 01/2023 - 08/2007
9	Carcinogenesis 01/2020 - 10/2007
8	Reperfusion Injury 01/2024 - 03/2005
8	Necrosis 01/2023 - 05/2006
7	Stroke (Strokes) 04/2024 - 08/2010
7	Stomach Neoplasms (Stomach Cancer) 12/2023 - 05/2017
7	Ischemia 11/2023 - 03/2005
7	Bacterial Infections (Bacterial Infection) 01/2023 - 02/2010
6	Bites and Stings (Sting) 01/2024 - 01/2021
6	Lymphoma (Lymphomas) 01/2024 - 01/2021
6	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 05/2012
6	Chronic Hepatitis B 10/2023 - 08/2007
6	Mitochondrial Diseases (Mitochondrial Disease) 11/2022 - 01/2016

Drug/Important Bio-Agent (IBA)

61	Proteins (Proteins, Gene)FDA Link 01/2024 - 09/2006
40	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2015
25	MicroRNAs (MicroRNA)IBA 11/2023 - 03/2014
19	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 08/2007
19	PlatinumIBA 02/2023 - 06/2004
18	Messenger RNA (mRNA)IBA 11/2023 - 06/2006
17	ErbB Receptors (EGF Receptor)IBA 04/2024 - 11/2013
17	EnzymesIBA 01/2024 - 12/2005
16	Long Noncoding RNAIBA 04/2023 - 06/2016
16	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 02/2003
14	Amyloid (Amyloid Fibrils)IBA 01/2024 - 08/2014
14	LigandsIBA 01/2023 - 04/2011
13	AntigensIBA 02/2024 - 05/2010
12	Cisplatin (Platino)FDA LinkGeneric 04/2024 - 06/2004
12	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2023 - 09/2011
11	Indicators and Reagents (Reagents)IBA 01/2024 - 07/2011
11	Therapeutic UsesIBA 11/2023 - 01/2009
10	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2021
10	Peptides (Polypeptides)IBA 01/2024 - 02/2010
10	RNA (Ribonucleic Acid)IBA 01/2023 - 09/2015
9	Tyrosine Kinase InhibitorsIBA 04/2024 - 11/2013
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 06/2006
8	AutoantibodiesIBA 05/2024 - 11/2011
8	LipidsIBA 03/2024 - 10/2019
8	ginsenoside Rg1IBA 01/2024 - 10/2006
8	InterferonsIBA 12/2023 - 08/2013
8	CytokinesIBA 11/2023 - 05/2011
8	Carbapenems (Carbapenem Antibiotics)IBA 06/2023 - 01/2018
8	Interleukin-6 (Interleukin 6)IBA 01/2023 - 10/2009
8	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2020 - 02/2011
7	CholesterolIBA 05/2024 - 01/2015
7	Insulin (Novolin)FDA Link 01/2024 - 12/2014
7	Immunoglobulin G (IgG)IBA 01/2024 - 05/2011
7	MetalsIBA 11/2023 - 01/2017
7	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2014
7	VaccinesIBA 11/2021 - 01/2009
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021 - 03/2007
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 08/2010
7	EndostatinsIBA 02/2005 - 04/2002
6	AntibodiesIBA 04/2024 - 05/2010
6	Circular RNAIBA 01/2024 - 03/2018
6	Adenosine Triphosphate (ATP)IBA 12/2023 - 03/2012
6	Transcription Factors (Transcription Factor)IBA 11/2023 - 02/2011
6	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2023 - 05/2006
6	AntioxidantsIBA 02/2023 - 03/2005

Therapy/Procedure

109	Therapeutics 04/2024 - 11/2002
50	Drug Therapy (Chemotherapy) 01/2024 - 06/2004
21	Immunotherapy 05/2024 - 07/2010
11	Secondary Prevention 01/2020 - 08/2010
9	Length of Stay 01/2024 - 04/2010
8	Percutaneous Coronary Intervention 01/2023 - 03/2014
8	Transcatheter Aortic Valve Replacement 11/2022 - 01/2020
7	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2024 - 10/2006
7	Radiotherapy 01/2022 - 09/2014
6	Lasers (Laser) 12/2023 - 01/2018